1. Home
  2. DELL vs JNJ Comparison

DELL vs JNJ Comparison

Compare DELL & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DELL

Dell Technologies Inc.

HOLD

Current Price

$424.59

Market Cap

191.7B

Sector

Technology

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$228.38

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DELL
JNJ
Founded
1984
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.7B
542.4B
IPO Year
2013
2003

Fundamental Metrics

Financial Performance
Metric
DELL
JNJ
Price
$424.59
$228.38
Analyst Decision
Buy
Buy
Analyst Count
17
20
Target Price
$181.63
$238.20
AVG Volume (30 Days)
10.0M
6.4M
Earning Date
05-28-2026
04-14-2026
Dividend Yield
1.23%
2.36%
EPS Growth
36.05
90.50
EPS
5.24
2.14
Revenue
$113,538,000,000.00
N/A
Revenue This Year
$26.19
$6.63
Revenue Next Year
$8.60
$7.43
P/E Ratio
$79.67
$108.94
Revenue Growth
18.80
N/A
52 Week Low
$110.22
$149.04
52 Week High
$469.47
$251.71

Technical Indicators

Market Signals
Indicator
DELL
JNJ
Relative Strength Index (RSI) 68.54 45.46
Support Level $122.88 $221.66
Resistance Level $469.47 $244.80
Average True Range (ATR) 29.76 4.53
MACD -2.68 0.12
Stochastic Oscillator 62.44 39.50

Price Performance

Historical Comparison
DELL
JNJ

About DELL Dell Technologies Inc.

Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: